Elgemtumab (LJM716) is a fully human IgG monoclonal antibody designed to selectively target and bind to human epidermal growth factor receptor 3 (HER3). By binding to HER3, Elgemtumab effectively blocks both ligand-dependent and independent signal transduction pathways, thereby inhibiting cellular proliferation. This targeted mechanism demonstrates significant potential in anti-tumor therapies, making it a valuable tool for oncological research and therapeutic development.
Elgemtumab (LJM716) is a fully human IgG monoclonal antibody designed to selectively target and bind to human epidermal growth factor receptor 3 (HER3). By binding to HER3, Elgemtumab effectively blocks both ligand-dependent and independent signal transduction pathways, thereby inhibiting cellular proliferation. This targeted mechanism demonstrates significant potential in anti-tumor therapies, making it a valuable tool for oncological research and therapeutic development.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
